These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36347733)

  • 1. 2022 Taiwanese Dermatological Association (TDA), Taiwanese Association for Psoriasis and Skin Immunology (TAPSI), and Taiwan Society of cardiology (TSOC) joint consensus recommendations for the management of psoriatic disease with attention to cardiovascular comorbidities.
    Chi CC; Wu YW; Chao TH; Chen CC; Chen YJ; Cheng HM; Chiu HY; Chiu YW; Chung WH; Hsieh TY; Huang PH; Huang YH; Lin SH; Lin TH; Ueng KC; Wang CC; Wang YC; Wu NL; Jia-Yin Hou C; Tsai TF
    J Formos Med Assoc; 2023 Jun; 122(6):442-457. PubMed ID: 36347733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology.
    Tsai TF; Hsieh TY; Chi CC; Chou CT; Hsieh LF; Chen HH; Hui RC; Lee CH; Liu CH; Liu HC; Yeo KJ; Chen CH; Chen HA; Chen YC; Chen YJ; Chiu HY; Ho JC; Huang YH; Lai PJ; Lee WR; Liao HT; Lin SH; Tseng JC; Wang TS; Wu NL; Yang DH; Tsai WC; Wei JC;
    J Formos Med Assoc; 2021 Mar; 120(3):926-938. PubMed ID: 33012636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
    Chiang CE; Lin SY; Lin TH; Wang TD; Yeh HI; Chen JF; Tsai CT; Hung YJ; Li YH; Liu PY; Chang KC; Wang KL; Chao TH; Shyu KG; Yang WS; Ueng KC; Chu PH; Yin WH; Wu YW; Cheng HM; Shin SJ; Huang CN; Chuang LM; Lin SJ; Yeh SJ; Sheu WH; Lin JL
    J Chin Med Assoc; 2018 Mar; 81(3):189-222. PubMed ID: 29453020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study.
    Chin YY; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1262-8. PubMed ID: 23004680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
    Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
    Armstrong AW; Gelfand JM; Boehncke WH; Armstrong EJ
    J Rheumatol; 2013 Aug; 40(8):1434-7. PubMed ID: 23908540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
    Chiang CE; Ueng KC; Chao TH; Lin TH; Wu YJ; Wang KL; Sung SH; Yeh HI; Li YH; Liu PY; Chang KC; Shyu KG; Huang JL; Tsai CD; Hung HF; Liu ME; Chao TF; Cheng SM; Cheng HM; Chu PH; Yin WH; Wu YW; Chen WJ; Lai WT; Lin SJ; Yeh SJ; Hwang JJ
    J Chin Med Assoc; 2020 Jul; 83(7):587-621. PubMed ID: 32628427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Link between Psoriasis and Cardiovascular Disease: Current Evidence, Therapeutic Implications and Perspectives.
    Kapniari E; Papadimitriou P; Dalamaga M; Makavos G; Piaserico S; Egeberg A; Ikonomidis I; Papadavid E
    Curr Vasc Pharmacol; 2020; 18(6):592-609. PubMed ID: 32445456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: A nationwide, population-based observational study in Taiwan.
    Wang TS; Hsieh CF; Tsai TF
    J Dermatol Sci; 2016 Dec; 84(3):340-345. PubMed ID: 27576765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis.
    Lin CP; Merola JF; Wallace EB
    Curr Opin Pharmacol; 2022 Dec; 67():102292. PubMed ID: 36228472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review.
    Kamata M; Tada Y
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?
    Lotti T; Hercogova J; Prignano F
    Dermatol Ther; 2010; 23(2):119-22. PubMed ID: 20415818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between psoriasis, psoriatic arthritis and gout: a nationwide population-based study.
    Hu SC; Lin CL; Tu HP
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):560-567. PubMed ID: 30317664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.
    Ogdie A; Schwartzman S; Eder L; Maharaj AB; Zisman D; Raychaudhuri SP; Reddy SM; Husni E
    J Rheumatol; 2014 Nov; 41(11):2315-22. PubMed ID: 25362717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of psoriasis with biologics: a survey of dermatological and rheumatological practice at Reims University Hospital].
    Adnot-Desanlis L; Brochot P; Eschard JP; Bernard P; Reguiaï Z
    Ann Dermatol Venereol; 2012 May; 139(5):355-62. PubMed ID: 22578339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
    Mease PJ; Armstrong AW
    Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis.
    Gottlieb AB; Merola JF
    J Dermatolog Treat; 2022 Jun; 33(4):1907-1915. PubMed ID: 34176399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.
    Coates LC; Soriano ER; Corp N; Bertheussen H; Callis Duffin K; Campanholo CB; Chau J; Eder L; Fernández-Ávila DG; FitzGerald O; Garg A; Gladman DD; Goel N; Helliwell PS; Husni ME; Jadon DR; Katz A; Laheru D; Latella J; Leung YY; Lindsay C; Lubrano E; Mazzuoccolo LD; Mease PJ; O'Sullivan D; Ogdie A; Olsder W; Palominos PE; Schick L; Steinkoenig I; de Wit M; van der Windt DA; Kavanaugh A;
    Nat Rev Rheumatol; 2022 Aug; 18(8):465-479. PubMed ID: 35761070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.